Login / Signup

Why only macro and not micro in type 2 diabetes? Time to change the goals of clinical trials in diabetes.

Ernesto MaddaloniRaffaella Buzzetti
Published in: Diabetes/metabolism research and reviews (2018)
Keyphrases
  • type diabetes
  • clinical trial
  • glycemic control
  • cardiovascular disease
  • phase ii
  • insulin resistance
  • open label
  • study protocol
  • phase iii
  • double blind